Hyperion Defi (HYPD) Non-Current Debt (2020 - 2026)
Hyperion Defi (HYPD) posted quarterly Non-Current Debt of $7.0 million for Q1 2026, up 770.69% year-over-year from $800000.0 in Q1 2025, and down 10.65% quarter-over-quarter from $7.8 million in Q4 2025.
Hyperion Defi (HYPD) Non-Current Debt (2020 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Non-Current Debt for 7 consecutive years, with $7.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Debt rose 770.69% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $7.0 million (up 770.69% YoY), while the FY2025 annual figure was $7.8 million, down 50.47% from the prior year.
- Non-Current Debt fell to $7.0 million in Q1 2026 per HYPD's latest filing, from $7.8 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $15.7 million in Q4 2024 and bottomed at $637500.0 in Q3 2024.
- Historically, Non-Current Debt has averaged $7.2 million across 5 years, with a median of $7.5 million in 2025.
- Annual changes were most pronounced in 2022 — Non-Current Debt soared 2524.07% — and 2024, when it tumbled 90.27%.
- Hyperion Defi's Non-Current Debt stood at $10.0 million in 2022, then slumped by 56.48% to $4.4 million in 2023, then soared by 261.37% to $15.7 million in 2024, then plunged by 50.47% to $7.8 million in 2025, then declined by 10.65% to $7.0 million in 2026.
- Business Quant data shows HYPD's Non-Current Debt at $7.0 million in Q1 2026, $7.8 million in Q4 2025, and $7.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 546.77 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 8.96 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 360.97 Mn |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | 5.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.64 Mn |
| Mar 31, 2026 | 6.97 Mn |
| Dec 31, 2025 | 7.80 Mn |
| Sep 30, 2025 | 7.66 Mn |
| Jun 30, 2025 | 7.52 Mn |
| Mar 31, 2025 | 800,000.00 |
| Dec 31, 2024 | 15.74 Mn |
| Sep 30, 2024 | 637,500.00 |
| Jun 30, 2024 | 4.80 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 4.36 Mn |
| Sep 30, 2023 | 6.55 Mn |
| Jun 30, 2023 | 14.80 Mn |
| Mar 31, 2023 | 8.76 Mn |
| Dec 31, 2022 | 10.01 Mn |
| Sep 30, 2022 | 7.50 Mn |
| Jun 30, 2022 | 7.73 Mn |
| Mar 31, 2022 | 8.06 Mn |
| Dec 31, 2021 | 7.50 Mn |
| Jun 30, 2021 | 6.99 Mn |